Face Forward® Aesthetics Expands Injectable Portfolio with Letybo®, South Korea's Leading Neurotoxin

Building on its established relationship with Hugel, the nurse practitioner-led practice brings expanded treatment options and Korean beauty innovation to guests across eight locations

COLUMBUS, Ohio, Oct. 19, 2026 /PRNewswire/ -- Face Forward® Aesthetics, a nurse practitioner-led medical aesthetics practice serving Ohio, Pennsylvania and Nevada, has expanded its injectable treatment portfolio with Letybo® (letibotulinumtoxinA-wlbg). Developed by South Korean medical aesthetics company Hugel, Letybo is FDA-approved for the temporary improvement of moderate to severe frown lines between the eyebrows in adults. The addition builds on Face Forward's longstanding relationship with Hugel as one of its early national partners.

The announcement highlights three key areas:

• Expanded Treatment Options: Letybo offers Face Forward guests another FDA-approved neurotoxin option, supporting individualized treatment plans.
• Established National Relationship: As one of Hugel's early national partners, Face Forward builds on an existing relationship to broaden access to Letybo through its network of clinics.
• Commitment to Clinical Excellence: The introduction reflects Face Forward's nurse practitioner-led approach to personalized care, continued education and thoughtful innovation.

As Korean beauty continues to shape global skincare and aesthetic trends, growing interest in slow aging and longevity reflects a shift toward more thoughtful, personalized approaches to beauty and wellness. Known as "K-Tox," Letybo is South Korea's No. 1 best-selling neurotoxin, backed by more than 15 years of global clinical experience.

"Face Forward's commitment to personalized, provider-led care aligns closely with Hugel's philosophy of K-Aesthetics, where individual beauty and thoughtful treatment approaches are at the center of everything we do," said Carrie Strom, Hugel Aesthetics Global CEO and President. "We're proud to build on our longstanding relationship with Face Forward as one of our early national partners, expanding access to Letybo, Korea's best-selling neurotoxin, through their trusted network of providers and clinics."

"Being first to introduce Letybo in the markets we serve reflects our dedication to staying at the forefront of aesthetic innovation," said Ashley Ponce, Chief Operating Officer of Face Forward Aesthetics. "We're always looking ahead at what's next in medical aesthetics, investing in provider education and thoughtfully evaluating new treatments that align with our commitment to clinical excellence. It's important to us that we're not just keeping up with the industry, but helping move it forward."

"I'm so excited to offer Letybo as another neurotoxin option for our guests, especially with all the attention Korean beauty and skincare are receiving right now," said Ellie Metzger, Lead Nurse Practitioner at Face Forward Aesthetics. "One of the things I love about Letybo is how quickly some patients begin noticing results. Hearing their positive feedback has been so rewarding, and I can't wait to introduce this option to more of our guests."

At Face Forward Aesthetics, injectable treatments begin with personalized consultations to understand each guest's aesthetic goals, medical history and treatment preferences. The addition of Letybo complements the practice's existing neurotoxin offerings, allowing providers to further individualize treatment recommendations.

The announcement follows Face Forward Aesthetics' recent brand refresh, redesigned website and expansion of advanced facial services, further reinforcing its commitment to nurse practitioner-led care, continued innovation and an elevated guest experience.

Guests interested in learning more about Letybo and exploring their injectable treatment options can visit Face Forward Aesthetics' dedicated Letybo treatment page for additional information and to schedule a personalized consultation.

About Face Forward Aesthetics

Founded in 2018, Face Forward Aesthetics is a nurse practitioner-led, multi-location medical aesthetics practice headquartered in the Columbus area, with clinics across Ohio, Pennsylvania and Nevada. The practice offers injectable treatments, advanced laser and skin-rejuvenation services and facials, with an emphasis on clinical expertise, individualized treatment plans and an approachable guest experience.

For more information, visit faceforwardaesthetics.com. Follow Face Forward on Instagram, Facebook and LinkedIn.

About Hugel

Established in 2001, Hugel is a global medical aesthetics company headquartered in South Korea, specializing in botulinum toxin products, hyaluronic acid dermal fillers and other aesthetic solutions. With a growing international presence, Hugel is committed to advancing aesthetic medicine through research, innovation and product development.

For more information, visit hugel-aesthetics.com.

MEDIA CONTACT

Laura Cassady
Vice President of Marketing
Face Forward Aesthetics
[email protected]

SOURCE Face Forward Aesthetics